The New MenB Vaccine Drive

 

Following a series of tragic, highly publicised outbreaks across the UK earlier this year, the government has announced a rapid, one-off rollout of the Meningitis B (MenB) vaccine.

Meningitis describes acute inflammation of the protective membranes that surround the brain and spinal cord, most commonly caused by viral or bacterial infection. Because this severe life-threatening infection progresses with frightening speed, everyone should memorise the early red flags and seek immediate medical review if these symptoms emerge:

  • A high temperature with cold hands and feet
  • A stiff neck and severe headache
  • Extreme sensitivity to bright lights
  • Confusion, drowsiness, or vomiting
  • (A rash that does not fade under a pressed glass often appears late)

Bacterial meningitis is the more concerning variant and different strains of this exist. Historically, the MenB vaccination has only been routinely given to infants, with vaccination against the ACWY strains given to teenagers in school year 9 since 2015. However, there is growing awareness that teenagers and young adults might face an elevated risk of contracting Meningitis B as immunity from infancy fades. Concern particularly centres around close-contact environments (halls of residence, shared houses, festivals) that allow the bacteria to spread rapidly via shared drinks, vapes, or kissing.

The free rollout of the MenB vaccine therefore targets two specific groups and will be offered via participating local pharmacies:

  • School Leavers: Pupils completing Year 13 this summer will be contacted directly by the NHS with an invitation to book their appointments.
  • New University Students: Anyone under 25 starting university for the first time this autumn will not be contacted automatically. Instead, they will need to contact participating pharmacies directly to book.

Best protection requires two doses given 28 days apart, with first doses offered at the end of July to ensure full immunisation before the autumn term.

Dr Chris Humphrey

Published: Jul 3, 2026